United States — Centers for Disease Control and Prevention & Moderna

United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention (CDC) advisory committee's formal recommendation is the next step after United States — Food and Drug Administration approval for the vaccine to be widely adopted and potentially made available for free with insurance. However, its current operations are in limbo due to a federal judge's ruling.

Moderna: Moderna is the developer of the mFlusiva mRNA flu vaccine, which is currently under review for approval by the United States — Food and Drug Administration. The positive recommendation from the advisory panel is a significant step towards market entry, potentially boosting its stock and market position in the vaccine sector.